Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innocan Pharma Corp (INNPF)

Innocan Pharma Corp (INNPF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 736,127 K
  • Annual Income, $ -9,489 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade INNPF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1995 unch
on 05/02/24
0.2311 -13.67%
on 04/03/24
-0.0105 (-5.00%)
since 03/22/24
3-Month
0.1995 unch
on 05/02/24
0.2311 -13.67%
on 04/03/24
+0.0041 (+2.10%)
since 02/02/24
52-Week
0.1450 +37.59%
on 08/11/23
0.3545 -43.72%
on 08/28/23
+0.0565 (+39.51%)
since 04/26/23

Most Recent Stories

More News
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma Initiates FDA Approval Process for Liposome Injection Therapy for Chronic Pain

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), is pleased to announce that is has reached a key...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma Reports Full Year 2023 Results with Revenues up Nearly 6X to $13.7M

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), a pharmaceutical technology company focusing on...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma paves its way to LPT-CBD Chemistry, Manufacturing and Controls (CMC), key milestones for FDA approval.

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of Approximately C$2 Million

/CNW/ -- Innocan Pharma Corporation (the "Company") (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) is pleased to announce that it has closed its previously announced...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma's LPT-CBD Has the Potential to Support a new Therapeutic Venue for Neurological Disorders According to Recent Study

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the development of drug delivery...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma Announces Study Findings that LPT-CBD maintains its prolonged release in Rabbits

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) ("Innocan" or the "Company"), a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma to participate in the White Label World Expo on February 27-28th, 2024

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to announce that CEO Iris Bincovich will be a...

BABA : 79.46 (+1.27%)
INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Provides Corporate Update & Preliminary Q4 and Fiscal Year 2023 Financial Highlights

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTC: INNPF) (the "Company" or "Innocan"), is pleased to provide the following corporate update:...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)
Innocan Pharma Announces Expert Team for LPT CBD Application to United States Food and Drug Administration

/CNW/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP4) (OTCQB: INNPF) (the "Company" or "Innocan") a pioneer in the pharmaceutical and biotechnology...

INNO.CN : 0.3300 (+15.79%)
INNPF : 0.1995 (-4.13%)

Key Turning Points

3rd Resistance Point 0.1995
2nd Resistance Point 0.1995
1st Resistance Point 0.1995
Last Price 0.1995
1st Support Level 0.1995
2nd Support Level 0.1995
3rd Support Level 0.1995

See More

52-Week High 0.3545
Fibonacci 61.8% 0.2745
Fibonacci 50% 0.2497
Fibonacci 38.2% 0.2250
Last Price 0.1995
52-Week Low 0.1450

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar